🌻

Gynaecology Nursing Guide GCC Edition

Ward & Outpatient Care — DHA / DOH / SCFHS Aligned • Updated April 2026

📋 Gynaecological Assessment

History Taking — Key Components

Menstrual & Obstetric History

  • LMP — Last Menstrual Period (date, flow, duration)
  • Menstrual cycle — frequency/regularity/duration/heaviness (PBAC score)
  • Obstetric history — G_P_ format (Gravida/Para); include deliveries, miscarriages, terminations, ectopics
  • Contraception — current method, duration, satisfaction, compliance
  • STI history — prior infections, treatments, partner notification

Screening & Pelvic Symptoms

  • Cervical screening history — last smear, any abnormalities, colposcopy history
  • Pelvic symptoms — dysmenorrhoea, dyspareunia (superficial/deep), dysuria, dyschezia, pelvic pressure, prolapse symptoms
  • Vaginal discharge — colour, odour, volume, associated symptoms
  • Postmenopausal bleeding — any episode warrants urgent investigation
  • Subfertility — duration of trying, investigations to date

Pelvic Examination Assistance

Mandatory: Chaperone required for ALL pelvic examinations — document name and role in notes.

Speculum Examination

Cusco Bivalve Technique

  • Select appropriate speculum size (small/medium/large)
  • Insert closed at 45° downward angle, then rotate to horizontal
  • Open blades slowly to visualise cervix
  • Tighten thumb screw to hold open

Swab Collection

  • High vaginal swab (HVS) — posterior fornix
  • Endocervical swab — rotate in endocervical canal ×5–10 seconds
  • Label, record time, transport in appropriate medium

Cervical Visualisation

  • Note: colour, ectropion, polyps, contact bleeding, nabothian cysts, lesions

Bimanual Examination

  • Two lubricated fingers inserted vaginally, non-dominant hand on abdomen
  • Assess: uterine size/position (anteverted/retroverted)/mobility/tenderness
  • Cervical excitation (motion tenderness) — indicates PID/ectopic
  • Adnexal tenderness or masses — note side, size, mobility
  • Recto-vaginal examination for posterior endometriosis (if indicated)

Cervical Screening — Liquid-Based Cytology (LBC)

Colposcopy Nursing

Preparation & Procedure Assistance

  • Confirm referral indication (HPV+/abnormal cytology/symptoms)
  • Obtain written consent; explain procedure clearly
  • Position in lithotomy; ensure adequate lighting
  • Acetic acid 3–5%: Apply to cervix — acetowhite areas indicate abnormal epithelium (CIN)
  • Lugol's iodine (Schiller's test): Normal glycogen-rich epithelium stains brown; abnormal unstained = iodine-negative
  • Assist with directed biopsy — punch biopsy forceps; apply Monsels paste for haemostasis

Post-Procedure Instructions — Colposcopy/LLETZ

Post-Colposcopy / LLETZ Discharge Instructions
  • Expect dark/black discharge (Monsels paste) for 1–2 weeks after biopsy
  • After LLETZ: light bleeding/discharge up to 4 weeks — normal
  • Seek urgent review if: heavy bleeding (soaking pad/hour), offensive discharge, fever >38°C, severe pelvic pain
  • No tampons, sexual intercourse, or swimming for 4 weeks post-LLETZ
  • Analgesia: paracetamol/ibuprofen for cramping
  • Results typically 4–6 weeks — ensure follow-up appointment booked
  • Advise regarding pregnancy — LLETZ marginally increases preterm birth risk; inform obstetric team in future pregnancy
  • Cervical screening recall as per colposcopy result letter

🧬 Benign Gynaecological Conditions

Uterine Fibroids (Leiomyomata)

Symptoms

  • Heavy menstrual bleeding (HMB) — most common; may cause iron-deficiency anaemia
  • Pelvic pressure / bulk symptoms — urinary frequency, constipation
  • Subfertility — distortion of uterine cavity (submucosal)
  • Acute pain — degeneration (red degeneration in pregnancy)
  • Many fibroids are asymptomatic — incidental finding on USS

Management Options

MedicalNotes
Tranexamic acidAnti-fibrinolytic; reduces HMB 50%
LNG-IUS (Mirena)Reduces HMB; may be expelled if cavity distorted
GnRH analoguesShrink fibroids pre-op; use ≤6 months; add-back HRT needed to prevent bone loss/menopausal symptoms
Ulipristal acetateSPRM; currently restricted — hepatic risk

Surgical

  • Myomectomy — fertility-preserving; laparoscopic/hysteroscopic/open
  • Hysterectomy — definitive treatment
  • UAE (Uterine Artery Embolisation) — interventional radiology; preserve uterus; post-procedure pain management key nursing role

Endometriosis

Average diagnostic delay: 7–10 years. Nurse advocacy and active listening are critical.

Classic Symptom Triad

  • Dysmenorrhoea — cyclical; begins before menstruation
  • Deep dyspareunia — posterior fornix tenderness
  • Dyschezia — painful defecation (posterior endometriosis)
  • + Chronic pelvic pain, subfertility, cyclical haematuria/rectal bleeding

Management Ladder

  1. NSAIDs + COCP (continuous to suppress cycles)
  2. Progestogens — Depo, Cerazette, Nexplanon, LNG-IUS
  3. GnRH analogues ± add-back HRT (≤6 months)
  4. Laparoscopic excision / ablation — gold standard diagnosis AND treatment
  5. Radical surgery — hysterectomy ± BSO (last resort)

Nursing role: Pain diary support, liaison with endometriosis specialist nurse, signposting to Endometriosis UK/regional support groups, holistic care including psychological wellbeing.

Ovarian Cysts

IOTA Criteria — Simple vs Complex

  • Simple (benign features): unilocular, no solid components, no blood flow, thin-walled
  • Complex (suspicious): multilocular, solid elements, ascites, bilateral, irregular wall
  • IOTA ADNEX model provides percentage malignancy risk

RMI (Risk of Malignancy Index)

RMI = U × M × CA125 (see interactive calculator in Tab 6)

  • RMI <25 — low risk
  • RMI 25–250 — moderate risk
  • RMI >250 — high risk / urgent oncology referral

Cyst Types & Management

TypeFeaturesManagement
FunctionalFollicular/luteal; resolves spontaneouslyRepeat USS 6–8 weeks
Dermoid (teratoma)Fat/hair/teeth on USS; bilateral 15%Laparoscopic cystectomy
Endometrioma"Ground glass" USS; chocolate cystLaparoscopic excision
Serous cystadenomaThin-walled, unilocularSurgical if large/symptomatic

Pelvic Floor Dysfunction & Prolapse

POP-Q Staging

StageDescription
0No prolapse
I>1 cm above hymen
IIWithin 1 cm of hymen (above or below)
III>1 cm below hymen but not complete eversion
IVComplete vault eversion

Conservative Management

  • Pelvic floor physiotherapy (PFPT) — first-line; Kegel exercises programme, supervised biofeedback
  • Ring pessary fitting: Select size by finger estimation of vaginal calibre; most common size 65–75 mm; check 6-weekly initially then 4–6 monthly
  • Pessary care: Remove, clean with warm water, reinsert. Teach patient self-management. Monitor for erosion/discharge
  • Local oestrogen cream improves tissue quality (peri/postmenopausal women)
  • Surgical repair — colposuspension, sacrocolpopexy, anterior/posterior repair

💉 Gynaecological Surgery

Pre-operative Preparation

VTE Prophylaxis

VTE is the leading cause of preventable surgical death. Ensure full risk assessment documented.
  • TED stockings: Measure and fit correctly; apply before induction; remove only when mobile
  • LMWH (e.g., enoxaparin): Commence 6–12 hours post-op; continue for 28 days post major cancer surgery; 7–10 days for benign surgery
  • Cauda equina/spinal: withhold LMWH as per anaesthetic guidance

Antibiotic Prophylaxis

  • Cefuroxime + metronidazole at induction for most gynaecological procedures
  • Hysterectomy: single-dose prophylaxis reduces SSI significantly
  • Allergy documentation critical — check and alert surgeon

Bowel Preparation

  • Indicated for: posterior vaginal wall repair, rectal endometriosis surgery, colorectal involvement
  • Phosphate enema or sodium picosulfate as prescribed
  • ERAS protocols may omit routine bowel prep for straightforward hysterectomy

Consent Checklist

  • Verify correct patient, correct procedure, correct site
  • Consent form signed and dated
  • Blood group and save/crossmatch as indicated
  • Pre-op investigations: FBC, U&E, LFTs, coagulation, ECG, CXR
  • NBM: 6 hours food, 2 hours clear fluids (ERAS)
  • VTE risk assessment form completed
  • Allergy wristband applied if applicable

Laparoscopic Surgery Nursing

Intra-operative Considerations

  • CO2 pneumoperitoneum: 12–15 mmHg intra-abdominal pressure; monitor for CO2 embolism
  • Patient position: Trendelenburg (head-down); padded shoulder stops; risk of brachial plexus injury
  • Port sites: typically 3–4 incisions; 5–12 mm; check for bleeding post-op

Post-operative

  • Shoulder tip pain: From residual CO2 irritating diaphragm — common; reassure; sitting upright + peppermint water helps
  • Port site care: small dressings; sutures/glue; observe for hernia (rare but port >10 mm requires fascial closure)
  • Day surgery: most laparoscopic cases; discharge criteria — mobile, tolerating fluids, pain controlled, micturated, responsible adult at home
  • Follow-up: GP or outpatient review; sick note requirements

Hysteroscopy — Fluid Deficit Monitoring

Hysteroscopy Distension Media Monitoring Protocol

Distension media types:

  • Saline (0.9% NaCl) — for diagnostic and bipolar operative hysteroscopy
  • Glycine 1.5% / Sorbitol — for monopolar electrosurgery (older systems)

Fluid deficit calculation: Fluid in − Fluid out (include all suction, swabs estimated)

Fluid deficit >1,000 mL (electrolyte-free media) or >2,500 mL (saline) = STOP procedure immediately

Complications of excess absorption:

  • Hyponatraemia → cerebral oedema → seizures (with hypotonic media)
  • Pulmonary oedema, fluid overload

Nursing actions on excess deficit:

  1. Alert surgeon immediately — stop distension pump
  2. Check serum electrolytes urgently (U&E)
  3. Monitor neurological status (GCS)
  4. IV access, ECG monitoring
  5. Consider furosemide per medical instruction
  6. Document all fluid volumes accurately

Hysterectomy — Types & Nursing Care

RouteIndicationsRecovery
Total Abdominal (TAH)Large uterus, cancer, endometriosis3–5 days inpatient; 6–8 weeks return to work
Vaginal (VH)Prolapse; smaller uterus2–3 days; faster recovery
Laparoscopic (TLH/LAVH)Endometriosis; fibroid uterus; cancer staging1–2 days; 2–4 weeks return to work
Robotic-assistedEndometrial cancer; complex cases1–2 days; specialist centre

Post-operative Assessment

  • Catheter care: Urethral catheter 24–48 hours; monitor output >0.5 mL/kg/hr; check colour; remove per protocol; trial of void documentation
  • Wound care: Pfannenstiel or midline — dressing check, signs of infection (REEDA scale)
  • Vaginal bleeding — light loss expected; heavy loss >normal period = escalate
  • Bowel function — usually returns 2–3 days; dietary advice

Return to Activities

  • No lifting >5 kg for 6 weeks (abdominal route)
  • No driving until off strong opioids and can perform emergency stop (typically 4–6 weeks open; 2–3 weeks laparoscopic)
  • No sexual intercourse for 6–8 weeks (vault healing)
  • No swimming/baths until wound/vault healed (~4 weeks)
  • Work: office 4–6 weeks (laparoscopic); 8–12 weeks (open)
  • Provide written information leaflet

Procedures Under GA vs Local Anaesthetic

LLETZ / Cone Biopsy (CIN Treatment)

  • LLETZ under local: 2% lidocaine + adrenaline injected paracervically
  • Cone biopsy under GA: for high-grade endocervical disease/adenocarcinoma in situ
  • Haemostasis: Monsels paste or diathermy
  • Specimen in formalin: labelled with 12 o'clock orientation suture

D&C (Dilatation & Curettage)

  • Now largely superseded by hysteroscopy
  • Used for: retained products of conception, endometrial sampling
  • Complications: uterine perforation, cervical laceration, Asherman's syndrome

Hysteroscopy Under GA

  • Indications: polypectomy, myomectomy (submucosal), septal resection, endometrial ablation
  • Operative vs diagnostic — fluid monitoring more critical for operative

Endometrial Ablation

  • 2nd generation: Novasure, Thermachoice — office/day case
  • Must exclude malignancy (biopsy) and pregnancy contraindicated post-ablation
  • Ensure reliable contraception discussed
  • 40–60% amenorrhoea rate; 80–90% satisfaction

🚨 Ectopic Pregnancy & Gynaecological Emergencies

Any woman of reproductive age with acute pelvic pain must have ectopic pregnancy excluded until proven otherwise.

Ectopic Pregnancy

Epidemiology & Risk Factors

  • Incidence: ~1 in 80 pregnancies; leading cause of maternal death in first trimester
  • Site: Fallopian tube (95%) — ampullary most common
  • Risk factors: Previous ectopic, PID/salpingitis, IUCD in situ, tubal surgery, IVF/assisted conception, endometriosis, smoking

Clinical Features

  • Classic triad: amenorrhoea + unilateral pelvic pain + vaginal bleeding
  • Shoulder tip pain (diaphragmatic irritation from haemoperitoneum)
  • Cervical excitation on examination
  • Ruptured ectopic: haemodynamic instability — tachycardia, hypotension, pallor, collapse — immediate surgical emergency

Investigations

  • Beta-hCG: Serial measurement every 48 hours — rising <66% suggests ectopic or non-viable pregnancy
  • Transvaginal USS (TVUSS): No intrauterine pregnancy (IUP) with beta-hCG >1,500–2,000 IU/L = suspicious
  • Progesterone level (if available)
  • FBC, group & save, U&E, LFTs (for methotrexate)

Ectopic Management Pathway

Ectopic Pregnancy Management Pathways
OptionCriteriaNursing Role
ExpectantDeclining beta-hCG, asymptomatic, <35 mm, no fetal heartbeatSerial hCG bloods, symptom monitoring, clear escalation advice
MethotrexatehCG <5,000, unruptured, no fetal heartbeat, size <35 mm, no contraindicationsIM injection; avoid folic acid; sun protection; contraception for 3 months; liver function monitoring
SurgicalHaemodynamically unstable, rupture, failed medical, patient preferenceEmergency prep: IV access x2, FBC/G&S/crossmatch, catheter, consent, theatre call, LMWH withheld, anti-D if Rh-negative

Salpingectomy vs Salpingotomy

  • Salpingectomy (tube removal) — preferred if contralateral tube healthy; reduces recurrent ectopic risk
  • Salpingotomy (tube preserved) — consider if contralateral tube damaged/absent; higher persistent trophoblast risk (monitor hCG post-op)
Anti-D immunoglobulin: Give 250–500 IU to all Rh-negative women within 72 hours of surgical or medical management.

Miscarriage

Emotional support is paramount. Use sensitive language — avoid "spontaneous abortion" in direct patient communication. Offer bereavement support/chaplaincy as appropriate.
TypeFindingsManagement Options
ThreatenedBleeding + closed os + viable IUP on USSExpectant; reassure; repeat USS 7–14 days
IncompleteOpen os; retained products on USSExpectant / medical (misoprostol) / surgical (ERPC)
CompleteNo products on USS; os may be closedConfirm with USS; no intervention usually needed
Missed (IUFD early)No fetal cardiac activity; intact sacExpectant (up to 2 weeks) / medical / surgical
Recurrent3+ consecutive lossesInvestigations: karyotype, thrombophilia, uterine anatomy, immune; refer specialist

Ovarian Torsion — Surgical Emergency

Ovarian torsion = time-critical surgical emergency. Delay risks permanent loss of ovarian function.

Clinical Features

  • Sudden-onset severe unilateral pelvic pain — may be colicky/intermittent
  • Often with nausea and vomiting
  • History of ovarian cyst (may be previously known)
  • Adnexal tenderness; palpable mass in 50%

Investigations & Management

  • Doppler USS: Absent or reduced venous flow (absent arterial flow = late sign); cyst usually present
  • Note: Doppler flow does NOT exclude torsion — clinical suspicion overrides
  • Bloods: FBC, CRP, beta-hCG (exclude ectopic)
  • Management: Emergency diagnostic laparoscopy — detorsion + cystectomy (fertility-preserving); oophorectomy if non-viable
  • Nil by mouth immediately; IV access; analgesia; theatre preparation

Acute Pelvic Inflammatory Disease (PID)

🏭 Gynaecological Oncology

Endometrial Cancer

Commonest UK Gynaecological Cancer

Key Points

  • Postmenopausal bleeding (PMB) = endometrial biopsy until proven otherwise — 2-week wait referral
  • Risk factors: obesity, DM, PCOS, nulliparity, unopposed oestrogen, Lynch syndrome, HRT (oestrogen-only)
  • Investigations: TVUSS (endometrial thickness >4 mm = biopsy), Pipelle biopsy, hysteroscopy, MRI staging

Management

  • LAVH / Robotic hysterectomy + BSO ± lymph node dissection (staging)
  • Adjuvant radiotherapy ± chemotherapy based on FIGO stage/grade
  • Fertility-sparing: High-dose progesterone (megestrol/LNG-IUS) for Grade 1 Stage 1A in young women — MDT decision; strict surveillance

Nursing Care

  • Pre-op: Enhanced recovery programme (ERAS); stoma nurse if bowel resection anticipated
  • Post-op: Catheter care, VTE prevention, wound surveillance, lymphoedema awareness
  • Psychological support — cancer diagnosis, fertility implications

Cervical Cancer

FIGO Staging (Summary)

StageExtent
IConfined to cervix
IIBeyond uterus, not pelvic wall/lower 1/3 vagina
IIIPelvic wall / lower vagina / hydronephrosis
IVBladder/rectum or distant metastases

Treatment & Nursing

  • Wertheim's (radical) hysterectomy: Stage IB1–IIA; radical parametrectomy + pelvic lymphadenectomy; risk bladder dysfunction, lymphoedema
  • Chemoradiotherapy: Cisplatin concurrent with external beam RT + brachytherapy; stages IIB+
  • Vaginal dilator use post-RT: Begin 4–8 weeks post-treatment; prevents vaginal stenosis; provide clear sensitive instruction and lubricant
  • HPV vaccine: Gardasil 9 — primary prevention; nationally delivered in UAE/Saudi/Qatar school programmes

Ovarian Cancer

Silent Killer — Often Stage III/IV at Diagnosis

Investigations

  • CA125: Raised in ~80% epithelial ovarian cancer; also raised in endometriosis, PID, fibroids (non-specific)
  • Pelvic USS: First-line imaging; complex cyst → RMI calculation
  • BRCA1/2 testing: Hereditary ovarian cancer (~15%); cascade testing for family
  • CT chest/abdomen/pelvis for staging

Chemotherapy Nursing

  • Carboplatin + Paclitaxel: First-line; IV 3-weekly × 6 cycles
  • Carboplatin: Myelosuppression — monitor FBC; renal function (AUC dosing); hypersensitivity reactions
  • Paclitaxel: Pre-medication required (dexamethasone + antihistamine + H2 blocker); peripheral neuropathy; alopecia
  • Bevacizumab (anti-VEGF): maintenance therapy — monitor BP; wound healing; proteinuria
  • PARP inhibitors (olaparib): BRCA-positive; oral maintenance

Vulval Cancer

Pathology

  • Predominantly squamous cell carcinoma (SCC)
  • VIN (Vulval Intraepithelial Neoplasia): Precancerous — HPV-related (usual VIN) or differentiated VIN (lichen sclerosus-related, higher malignant risk)
  • Present as: pruritis vulvae, visible lesion, bleeding, ulcer

Surgery & Nursing

  • Radical vulvectomy + bilateral inguino-femoral lymph node dissection
  • Wound care: Complex perineal wound; daily wound assessment; bidet/sitz baths; barrier cream; VAC dressing if large defect
  • Lymphoedema prevention: SLD (simple lymphatic drainage) teaching; compression hosiery; leg elevation; avoid trauma/infection to legs
  • Body image and sexuality concerns — specialist nurse counselling; psychosexual referral
  • Urinary: catheter care; suprapubic catheter if urethral involvement

🇪🇪 GCC Context, RMI Calculator & Exam MCQs

Female Gynaecological Health in the GCC

Cultural Considerations

  • Female gynaecologist preference: Strong cultural and religious preference in many GCC patients; wherever possible, arrange female clinician; male clinician must always have female chaperone
  • Delayed presentation: Stigma around gynaecological symptoms (especially sexual health, menstrual disorders, pelvic pain) leads to delayed diagnosis — particularly endometriosis, STIs, vulval conditions
  • Modesty: Minimise exposure; provide abaya/gown; ensure privacy; involve female relatives if culturally appropriate and patient consents
  • Language: Professional interpreter services — do not use family members for sensitive gynaecological history

Ramadan Scheduling

  • Hysteroscopy, colposcopy, biopsy procedures — schedule in the evening or outside fasting hours where possible, or defer if patient requests
  • Medications: IV medications do not break fast (Islamic scholarly consensus); oral medications — patient may prefer to defer to non-fasting hours
  • Anaesthesia: elective procedures may be postponed per patient preference during Ramadan

Islamic Considerations — Contraception & Sterilisation

  • Contraception: Generally permissible (mubah) for family planning — reversible methods widely accepted (COCP, IUS, IUCD, condoms, Depo)
  • Emergency contraception: Permissible before implantation (scholarly consensus varies); provide information and respect patient autonomy
  • Permanent sterilisation (tubal ligation/vasectomy): Subject to scholarly debate; majority view — permissible for medical necessity or completed family with scholar consultation; not uniformly endorsed for convenience only
  • Nursing role: Non-judgmental counselling; present all options; document discussion

Cervical Screening Uptake — GCC Challenge

  • Suboptimal uptake across most GCC countries vs Western populations
  • Barriers: stigma, low perceived risk, cultural modesty, lack of awareness, no symptoms
  • Nursing role: Patient education; opportunistic screening invitation; address misconceptions; emphasise HPV vaccine + cervical screening complementary (not alternative)

PCOS Prevalence in GCC

PCOS is highly prevalent in GCC populations — estimates 15–20%, amongst highest globally, linked to high rates of obesity and type 2 diabetes.

Rotterdam Criteria (2 of 3)

  1. Oligo/anovulation (irregular periods)
  2. Clinical or biochemical hyperandrogenism (acne/hirsutism/elevated androgens)
  3. Polycystic ovaries on USS (≥12 follicles 2–9 mm per ovary, or ovarian volume >10 mL)

Management

  • Lifestyle: 5–10% weight loss restores ovulation in many women
  • Metformin: Insulin sensitiser; improves cycle regularity; reduces DM risk; first-line in GCC given high metabolic risk
  • Clomifene citrate: Ovulation induction for subfertility
  • Letrozole: Aromatase inhibitor; emerging as preferred ovulation induction agent
  • COCP: Menstrual regulation + anti-androgen effects
  • Screen annually: fasting glucose, HbA1c, lipids, BP

Endometrial Cancer Risk in GCC

GCC populations face elevated endometrial cancer risk due to convergence of obesity + type 2 diabetes + PCOS + nulliparity. Earlier onset (perimenopausal rather than postmenopausal) reported. Any irregular/heavy bleeding in high-risk patients warrants endometrial sampling regardless of age.

DHA / DOH / SCFHS Competencies

DHA & DOH (UAE) Gynaecology Nursing

  • Competency framework includes: gynaecological assessment skills, specimen collection, pre/post-operative care, patient education delivery
  • Nurses must demonstrate competency in: chaperone policy compliance, consent documentation, VTE prophylaxis administration
  • Mandatory training: infection control, safeguarding, cultural competency
  • Speculum examination and LBC sampling requires specific accreditation

SCFHS (Saudi Arabia)

  • Gynaecology nursing content within SCFHS prometric examination covers: obstetric and gynaecological nursing, women's health, surgical nursing
  • Key exam areas: normal reproductive physiology, menstrual cycle, pelvic examination technique, common gynaecological disorders, cancer screening
  • SCFHS classification: Registered Nurse — requires competency across women's health domains including gynaecological nursing care
  • Continuing professional development (CPD) mandatory — 30 hours/year minimum

🧮 Risk of Malignancy Index (RMI) Calculator

RMI = U × M × CA125. Used to stratify ovarian cysts for malignancy risk and guide referral pathway.

USS features: multilocular cyst / solid areas / metastases / ascites / bilateral lesions

Normal range: <35 IU/mL. Enter the numerical value.


🎓 GCC Exam MCQs — Gynaecology Nursing

Click an option to reveal the answer and explanation.

1. A 34-year-old woman presents to a GCC outpatient clinic with heavy menstrual bleeding, pelvic pressure and a uterus palpable to the umbilicus. Ultrasound confirms multiple large fibroids. Which GnRH analogue side effect requires mandatory co-prescription of add-back HRT?
A. Nausea and vomiting
B. Vaginal discharge
C. Bone loss and menopausal symptoms due to hypoestrogenism
D. Thrombocytopenia
GnRH analogues (e.g., leuprorelin, goserelin) suppress oestrogen to castrate levels, causing menopausal symptoms (hot flushes, vaginal dryness) and — critically — bone mineral density loss. Add-back HRT (low-dose oestrogen ± progestogen) is prescribed to mitigate these effects, especially when treatment extends beyond 3–6 months. The other options are not characteristic class effects of GnRH analogues.
2. During operative hysteroscopy for endometrial polyp removal, you note the fluid deficit has reached 1,800 mL using glycine 1.5% (electrolyte-free hypotonic media). What is your immediate priority action?
A. Document and continue monitoring
B. Alert the surgeon immediately to stop the procedure and check serum electrolytes
C. Increase IV fluid rate to compensate
D. Administer furosemide 40 mg without awaiting electrolyte results
With electrolyte-free (hypotonic) distension media such as glycine, the critical fluid deficit threshold is 1,000 mL — not 2,000 mL. At 1,800 mL the threshold has been significantly exceeded. The immediate priority is to stop the distension medium infusion and alert the surgeon to cease the procedure, followed by urgent serum electrolyte measurement (risk of dilutional hyponatraemia → cerebral oedema → seizures). Furosemide should only be given on medical prescription after electrolyte results. Continuing or adding IV fluids could worsen fluid overload.
3. A Rh-negative woman undergoes surgical management (ERPC) for an incomplete miscarriage at 10 weeks gestation in a GCC hospital. Which of the following is the correct anti-D immunoglobulin dose and timing?
A. 500 IU within 7 days
B. 250 IU within 72 hours of the procedure
C. 1000 IU within 24 hours
D. Anti-D is not required as gestation is under 12 weeks
For sensitising events under 20 weeks gestation (including surgical management of miscarriage, ectopic pregnancy surgery, invasive procedures), the recommended dose is 250 IU IM anti-D immunoglobulin, administered within 72 hours. This prevents Rhesus isoimmunisation which could affect future pregnancies. Anti-D IS required for surgical management regardless of gestation; expectant and medical management under 12 weeks has variable guidance, but surgical management warrants anti-D at any gestation.
4. A 45-year-old Saudi woman presents with postmenopausal bleeding for 3 months. She has a BMI of 38 and type 2 diabetes. Transvaginal USS shows endometrial thickness of 9 mm. Which is the most appropriate next investigation?
A. MRI pelvis
B. CA125 level
C. Endometrial biopsy (Pipelle or hysteroscopy-directed biopsy)
D. Repeat USS in 6 weeks
Postmenopausal bleeding with endometrial thickness >4 mm (some guidelines use >3 mm) mandates endometrial biopsy to exclude endometrial carcinoma. This patient has multiple risk factors for endometrial cancer (obesity BMI 38, type 2 diabetes — both cause hyperinsulinaemia and excess oestrogen from adipose aromatisation). Pipelle outpatient biopsy or hysteroscopy-directed biopsy are appropriate. MRI is useful for staging after malignancy is confirmed; CA125 is not a primary diagnostic tool for endometrial cancer; delaying with repeat USS is inappropriate.
5. In the GCC context, which of the following best describes the Islamic scholarly position on permanent female sterilisation (tubal ligation) for a healthy woman with 4 children who wishes no further pregnancies?
A. Universally prohibited (haram) under all circumstances
B. Subject to scholarly debate — generally not endorsed for convenience alone; may be permissible with medical indication or scholarly guidance
C. Universally permissible (halal) for any woman over 40
D. Permissible only if approved by the husband
The Islamic position on permanent sterilisation is nuanced. The majority scholarly view holds that permanent sterilisation for convenience (without medical necessity) is generally discouraged (makruh to haram in different schools), as it permanently alters reproductive capacity. However, if there is a compelling medical reason or completion of family is confirmed, many scholars permit it following consultation. Reversible contraception is widely favoured. Critically, from a nursing perspective, the woman's autonomy must be respected; the nurse's role is to provide complete, unbiased information about all options and support the patient's informed decision — not to impose or withhold options.